Effectiveness of rehabilitation interventions in adults with multi-organ dysfunction syndrome: A rapid review
DOI:
https://doi.org/10.2340/16501977-2846Keywords:
multiple organ failure, rehabilitation, rapid reviewAbstract
Background: Multiple organ dysfunction syndrome, defined as altered organ function in critically ill patients, is a possible consequence of COVID-19. Investigating the current evidence is therefore crucial in this pandemic, as early rehabilitation could be effective for the functioning of patients with multiple organ failure. This rapid review assesses the effectiveness of rehabilitation interventions in adults with multiple organ dysfunction syndrome.
Methods: A rapid review was conducted including only randomised control trials, published until 30 November 2020. All databases were investigated and the results synthesized narratively, evaluating the risk of bias and quality of evidence in all included studies.
Results: A total of 404 records were identified through database searches. After removal of duplicates 346 articles remained. After screening, 3 studies (90 participants) met the inclusion criteria. All studies reported positive effects of neuromuscular electrical stimulation on muscle mass preservation compared with no treatment or standard physiotherapy.
Conclusion: The lack of evidence on the effectiveness of rehabilitation interventions does not allow any firm conclusion to be drawn. Neuromuscular electrical stimulation might be a possible rehabilitation intervention to prevent muscle volume loss and improve function in patients with multiple organ dysfunction syndrome. However, further studies are needed to support these preliminary findings.
Lay AbstractThis paper synthesizes the current evidence on the effects of rehabilitation interventions in patients with multi-organ dysfunction syndrome. The results show that neuromuscular electrical stimulation may be a feasible treatment to prevent muscle mass loss and increase upper and lower limb strength in this population. Following multi-organ dysfunction syndrome people frequently experience new or worsened disabilities. Therefore, it is relevant to provide the clinician with the best current evidence on treatment that could be applied in the acute phase, in order to enhance the recovery of these patients. This is even more applicable while the COVID-19 pandemic is raging globally, as multi-organ dysfunction syndrome is one of the worst possible consequences of the disease.
Downloads
References
Gourd NM, Nikitas N. Multiple organ dysfunction syndrome. J Intensive Care Med 2020; 35: 1564–1575.
Mizock B. The multiple organ dysfunction syndrome. Dis Mon DM 2009; 55: 476–526.
Murray MJ, Coursin DB. Multiple organ dysfunction syndrome. Yale J Biol Med 1993; 66: 501–510.
Gosselink R, Needham D, Hermans G. ICU-based rehabilitation and its appropriate metrics. Curr Opin Crit Care 2012; 18: 533–539.
Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000; 16: 337–352, vii.
Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009; 37: 1649–1654.
Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754–1758.
Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J-L. Sepsis and septic shock. Nat Rev Dis Primer 2016; 2: 16045.
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol Orlando Fla 2020; 215: 108427.
Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, et al. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care 202; 1: 73.
Tricco AC, Garritty CM, Boulos L, Lockwood C, Wilson M, McGowan J, et al. Rapid review methods more challenging during COVID-19: commentary with a focus on 8 knowledge synthesis steps. J Clin Epidemiol 2020; 126: 177–183.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 2009; 6: e1000097.
Garritty C, Gartlehner G, Kamel C, King VJ, Nussbaumer-Streit B, Stevens A, et al. Cochrane Rapid Reviews. Interim Guidance from the Cochrane Rapid Reviews Methods Group. Mar 2020. [Cited 2021 Feb 11]. Available from: https: //methods.cochrane.org/rapidreviews/sites/methods.cochrane.org.rapidreviews/files/public/uploads/cochrane_rr_-_guidance-23mar2020-final.pdf.
Vincent J-L, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707–710.
Levack WMM, Rathore FA, Pollet J, Negrini S. One in 11 Cochrane reviews are on rehabilitation interventions, according to pragmatic inclusion criteria developed by Cochrane Rehabilitation. Arch Phys Med Rehabil 2019; 100: 1492–1498.
Garritty C, Gartlehner G, Kamel C, King VJ, Nussbaumer-Streit B, Stevens A, Hamel C, Affengruber L. Cochrane Rapid Reviews. Interim Guidance from the Cochrane Rapid Reviews Methods Group. Mar 2020. [Cited 2021 Feb 11]. Available from: https: //apps.who.int/classifications/icfbrowser/.
Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated Feb 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook. [Cited 2021 Feb 12]. Available from: /handbook/current/chapter-08.
Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated Feb 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook. [Cited 2021 Feb 12]. Available from: /handbook/current/chapter-14.
Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care Lond Engl 2009; 13: R161.
Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, et al. Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation. J Crit Care 2012; 27: 319.e1–8.
Wollersheim T, Grunow JJ, Carbon NM, Haas K, Malleike J, Ramme SF, et al. Muscle wasting and function after muscle activation and early protocol-based physiotherapy: an explorative trial. J Cachexia Sarcopenia Muscle 2019; 10: 734–747.
Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003; 29: 1505–1514.
Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care Lond Engl 2015; 19: 274.
Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg 1998; 228: 146–158.
Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008; 36: 2238–2243.
Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46: e825–e873.
Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 2009; 37: 2499–2505.
Nunan D, Aronson J, Bankhead C. Catalogue of bias: attrition bias. BMJ Evid-Based Med 2018; 23: 21–22.
Saric F, Barcot O, Puljak L. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews. J Clin Epidemiol 2019; 112: 535–538.
Armijo-Olivo S, Dennett L, Arienti C, Dahchi M, Arokoski J, Heinemann AW, et al. Blinding in rehabilitation research: empirical evidence on the association between blinding and treatment effect estimates. Am J Phys Med Rehabil 2020; 99: 198–209.
Additional Files
Published
How to Cite
License
Copyright (c) 2021 Chiara Arienti, Stefano G. Lazzarini, Elisa Pollini, Michele Patrini, Carlotte Kiekens, Stefano Negrini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.
